Cargando…

Combined detection of the expression of Nm23-H1 and p53 is correlated with survival rates of patients with stage II and III colorectal cancer

Molecular tumor markers hold considerable promise for accurately predicting the recurrence and progression of colorectal cancer (CRC) in patients. However, in the majority of cases, single marker analysis has been found to have low accuracy, and is of little practical use in clinical practice. The p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yinying, Li, Yi, Zhao, Xiaoai, Dong, Danfeng, Tang, Chunhui, Li, Enxiao, Geng, Qianqian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244864/ https://www.ncbi.nlm.nih.gov/pubmed/28123532 http://dx.doi.org/10.3892/ol.2016.5425

Ejemplares similares

PD-L1 and PD-1 expression correlate with prognosis in extrahepatic cholangiocarcinoma
por: Ma, Ke, et al.
Publicado: (2017)

A Sensitive and Selective Method for Determination of Aesculin in Cortex Fraxini by Liquid Chromatography Quadrupole Time-of-Flight Tandem Mass Spectrometry and Application in Pharmacokinetic Study
por: Li, Yi, et al.
Publicado: (2013)

Impact of neoadjuvant and adjuvant radiotherapy on disease-specific survival in patients with stages II–IV rectal cancer
por: Wu, Yinying, et al.
Publicado: (2017)

PIK3CA and TP53 mutations predict overall survival of stage II/III colorectal cancer patients
por: Li, A-Jian, et al.
Publicado: (2018)

The risk and survival outcome of subsequent primary colorectal cancer after the first primary colorectal cancer: cases from 1973 to 2012
por: Yang, Jiao, et al.
Publicado: (2017)

Molecular classification of esophagogastric junction carcinoma correlated with prognosis
por: Zou, Long, et al.
Publicado: (2017)

Prognostic value of PD-L1 and PD-1 expression in pulmonary neuroendocrine tumors
por: Fan, Yangwei, et al.
Publicado: (2016)

α‐Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades
por: Shi, Yu, et al.
Publicado: (2019)

Efficacy and safety of regorafenib as beyond second-line therapy in patients with metastatic colorectal cancer: an adjusted indirect meta-analysis and systematic review
por: Wu, Yinying, et al.
Publicado: (2020)

Vitamin D Status and Survival in Stage II-III Colorectal Cancer
por: Bao, Yichao, et al.
Publicado: (2020)

Nomogram for predicting overall survival in stage II‐III colorectal cancer
por: Liu, Jungang, et al.
Publicado: (2020)

NM23-H1 immunostaining is inversely associated with tumour staging but not overall survival or disease recurrence in colorectal carcinomas.
por: Cheah, P. Y., et al.
Publicado: (1998)

Microsatellite instability & survival in patients with stage II/III colorectal carcinoma
por: Srdjan, Markovic, et al.
Publicado: (2016)

Prognostic Factors Influencing Survival in Stage II and Stage III Colorectal Cancer Patients
por: Alkader, Mohammad S, et al.
Publicado: (2023)

Survival nomograms for stage III colorectal cancer
por: Li, Chenglong, et al.
Publicado: (2018)

Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma
por: Du, Peng, et al.
Publicado: (2016)

Tumor location as a novel high risk parameter for stage II colorectal cancers
por: Wang, Biyuan, et al.
Publicado: (2017)

Association of Tumor-Infiltrating Lymphocytes With Survival in Stages II and III Colorectal Cancer
por: Vitorino, Marina, et al.
Publicado: (2022)

Prognostic Factors for Post-Recurrence Survival in Stage II and III Colorectal Carcinoma Patients
por: Nikolic, Neda, et al.
Publicado: (2021)

Correction: Association of Tumor-Infiltrating Lymphocytes With Survival in Stages II and III Colorectal Cancer
por: Vitorino, Marina, et al.
Publicado: (2023)

MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer
por: Ma, Ke, et al.
Publicado: (2017)

Expression of nm23‐Hl and nm23‐H2 Proteins in Prostate Carcinoma
por: Konishi, Noboru, et al.
Publicado: (1993)

Whole genome analysis identifies the association of TP53 genomic deletions with lower survival in Stage III colorectal cancer
por: Xia, Li C., et al.
Publicado: (2020)

Prognostic role of FUT8 expression in relation to p53 status in stage II and III colorectal cancer
por: Noda, Masaru, et al.
Publicado: (2018)

p53 expression status is associated with cancer-specific survival in stage III and high-risk stage II colorectal cancer patients treated with oxaliplatin-based adjuvant chemotherapy
por: Oh, Hyeon Jeong, et al.
Publicado: (2019)

The association between nm23 gene expression and survival in patients with sarcomas.
por: Royds, J. A., et al.
Publicado: (1997)

Expression of nm23-H1 and nm23-H2 protein in endometrial carcinoma.
por: Watanabe, J., et al.
Publicado: (1995)

Thrombospondin 4/integrin α2/HSF1 axis promotes proliferation and cancer stem-like traits of gallbladder cancer by enhancing reciprocal crosstalk between cancer-associated fibroblasts and tumor cells
por: Shi, Yu, et al.
Publicado: (2021)

Regulatory activity based risk model identifies survival of stage II and III colorectal carcinoma
por: Liu, Gang, et al.
Publicado: (2017)

Mutation of the nm23 gene, loss of heterozygosity at the nm23 locus and K-ras mutation in ovarian carcinoma: correlation with tumour progression and nm23 gene expression.
por: Mandai, M., et al.
Publicado: (1995)

High levels of Nm23 gene expression in advanced stage of thyroid carcinomas.
por: Zou, M., et al.
Publicado: (1993)

Apatinib inhibits pancreatic cancer growth, migration and invasion through the PI3K/AKT and ERK1/2/MAPK pathways
por: Hu, Yuan, et al.
Publicado: (2021)

Identification and characterization of ANO9 in stage II and III colorectal carcinoma
por: Li, Chunxiang, et al.
Publicado: (2015)

Expression of p53 and NDP-K/nm23 in gastric carcinomas--association with metastasis and clinicopathologic parameters.
por: Kim, K. M., et al.
Publicado: (1995)

Neutrophil to lymphocyte ratio can predict overall survival in patients with stage II to III colorectal cancer
por: Cho, Yerim, et al.
Publicado: (2023)

Impact of Postoperative Naples Prognostic Score to Predict Survival in Patients with Stage II–III Colorectal Cancer
por: Park, Su Hyeong, et al.
Publicado: (2023)

Clinical characteristics and treatment of 69 patients with extranodal natural killer T-cell lymphoma
por: Guo, Yuyan, et al.
Publicado: (2016)

Comprehensive investigation of p53, p21, nm23, and VEGF expression in hepatitis B virus-related hepatocellular carcinoma overall survival after hepatectomy
por: Zhu, Guang-Zhi, et al.
Publicado: (2020)

High-throughput proteomics profiling-derived signature associated with chemotherapy response and survival for stage II/III colorectal cancer
por: Ye, Shu-Biao, et al.
Publicado: (2023)

Expression and mutational analysis of Nm23-H1 in liver metastases of colorectal cancer.
por: Heide, I., et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_06nusser207ot09i09uuo0cn4a